Wyss Center for Bio and Neuroengineering
Craig Cook, Head of Business Development & Licensing at the Wyss Center for Bio and Neuroengineering, is a seasoned executive with a strong background in the healthcare and life sciences industry. Craig brings expertise from their roles as Chairman at Precihealth, Founder Partner at CareHealth, and Founder Partner at Longevity Clinical, among others. Their leadership experience at companies like Herantis Pharma Plc. and Midatech Pharma PLC showcases their dedication to advancing therapies for neurodegenerative diseases. With a diverse educational background including degrees in medicine, business administration, and pharmaceutical sciences, Cook is a well-rounded and accomplished professional in the field.
This person is not in any teams
Wyss Center for Bio and Neuroengineering
The Wyss Center is an independent, non-profit, research organization that innovates and accelerates technologies and therapies to transform the lives of people with neurological and mental health disorders. The Center pursues transformational technologies in artificial intelligence, bio- and neuroengineering to restore essential neural functions and deliver precision therapeutics for people with debilitating neurological and mental health disorders. Based at Campus Biotech in Geneva, Switzerland, the Wyss Center partners with faculty, clinicians and industry, in Switzerland and internationally, to drive innovation and maximize clinical impact. The Wyss Center was established by a generous donation from the Swiss entrepreneur and philanthropist Hansjörg Wyss in 2014. Additional resources from funding agencies and other sources help the Wyss Center achieve its mission. Subscribe to our updates - https://wysscenter.ch/newsletter